Alumis Inc. stocks have been trading up by 10.61 percent following upbeat sentiment around its latest clinical trial progress.
Click Here for a Millionaire's POV on Trading ALMS
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Price action in ALMS shows a sharp fade from the low-$20s to around $10, signaling heavy post-IPO profit-taking and supply.
- Intraday trading in Alumis Inc. is tightening near $10, with a clear battle between dip buyers and those bailing on the downtrend.
- ALMS posts roughly $1.7M in quarterly revenue against more than $140M in losses, a classic early-stage biotech profile.
- Alumis Inc. holds over $500M in cash and short-term investments, giving ALMS a sizable funding runway despite steep negative cash flow.
- Traders are watching whether ALMS can build support near $10 or breaks lower as early momentum fades.
Live Update At 12:32:06 EDT: On Wednesday, September 02, 2026 Alumis Inc. stock [NASDAQ: ALMS] is trending up by 10.61%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
Alumis Inc., trading under the ticker ALMS, is acting like a textbook early-stage biotech: small revenue, heavy burn, big cash cushion. For the latest reported quarter in 2026, ALMS generated about $1.7M in total revenue while posting a net loss of roughly $142M. That translates into a highly negative profit margin and explains why the key ratios show return on assets near -53% and return on equity around -66%.
Yet the balance sheet is strong for now. ALMS reports about $502M in cash and short-term investments and total assets of roughly $560.6M, with total liabilities near $108.5M. That leaves common stock equity around $452.2M and a current ratio of 6.7, which signals ample liquidity.
More Breaking News
- CANF Stock Jolted As $100M Shelf Registration Hits Tape
- JLHL Stock Slides As Momentum Traders Hunt Support
- ALNY Stock Rebounds As Analysts Back RNAi Pipeline Strength
- RDDT Stock Surges As S&P 500 Inclusion Triggers Momentum
For traders, this sets up a classic “story stock” structure. ALMS has minimal revenue today but a large R&D line — about $85M in the quarter — and a long runway funded mainly by equity. That combination often drives volatile trading as sentiment swings between enthusiasm for the pipeline and fear of ongoing dilution and losses.
Why Traders Are Watching ALMS Price Action
ALMS grabbed traders’ attention right out of the gate, running into the mid-$20s after listing, then giving back a massive chunk of that move. On 2026/08/14, Alumis Inc. closed around $25.31 after hitting $25.38. By 2026/08/19, ALMS was still near $23.99. Then the real slide started. After several sessions drifting lower in the $22–$24 range, the stock collapsed from a $22.29 open on 2026/08/31 to a $21.81 close, and then gapped down hard.
The latest daily data shows ALMS closing at $9.47 on 2026/09/01 before bouncing modestly to $10.48 on 2026/09/02. That is more than a 50% drawdown from the August highs. For short-term traders, Alumis Inc. has already offered a full boom-and-bust cycle.
Zooming into the intraday 5-minute chart, the story is one of early volatility fading into consolidation. ALMS dipped under $10.00 at the open, flushed to about $10.05, then spiked to $10.77 in the first half hour. From there, the stock chopped in a tight band between roughly $10.30 and $10.60 for most of the session, closing near $10.48. That sideways action after a big multi-day selloff often signals a pause where both long and short traders reassess their positions.
Put simply, ALMS has transitioned from wild IPO momentum into a more technical, level-by-level trading environment. Breaks above intraday highs or under the morning low now matter more than hype. Active traders in Alumis Inc. will be watching for range breaks, volume surges, and failed bounces as clear tells for the next directional move.
Conclusion
Alumis Inc. sits at an interesting crossroads. ALMS has a massive cash pile, light debt, and heavy R&D spend — the kind of setup that can attract speculative trading around any hint of clinical or strategic progress. At the same time, the company’s current fundamentals are harsh: more than $140M in quarterly losses on just over $1.6M in revenue, with deeply negative margins and free cash flow around -$81.7M.
The chart confirms the tug-of-war. ALMS ripped to the mid-$20s, then bled down into the $9–$10 zone where the stock is now trying to build a base. Liquidity and market cap still support active trading, but the easy early momentum is gone. Now ALMS is all about discipline — sticking to your plan, honoring stops, and focusing on clean chart patterns.
For traders studying Alumis Inc., the key is to treat it as a trading vehicle, not a prediction about the future of its pipeline. As Tim Sykes likes to say, “Trade the price action, not the hype.” That lines up with the mindset emphasized by trading mentors: As Tim Bohen, lead trainer with StocksToTrade says, “The best trades are the ones you can make without emotion. Plan it, then execute it as if it’s routine.”. If ALMS holds the $10 area and starts to trend, that price action will show up on the chart. If it cracks and flushes lower, that will show too. Either way, the edge goes to traders who respect the volatility, size properly, and cut losses fast.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.